These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29483801)

  • 41. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
    Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.
    Gupta A; Singh M; Singh H; Kumar L; Sharma A; Bakhshi S; Raina V; Thulkar S
    Med Oncol; 2010 Dec; 27(4):1037-45. PubMed ID: 19830601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies.
    Rintala E
    Scand J Infect Dis; 1994; 26(1):77-84. PubMed ID: 8191244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy.
    Chen CY; Tang JL; Hsueh PR; Yao M; Huang SY; Chen YC; Chen YC; Shen MC; Wang CH; Tsai W; Chang SC; Tien HF; Luh KT
    J Formos Med Assoc; 2004 Jul; 103(7):526-32. PubMed ID: 15318274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of Antimicrobial Sensitivity in Microbiologically Documented Infections in Neutropenic Patients with Haematological Malignancies: A single Center Study.
    Jamal A; Fatima N; Shaikh S; Kaleem B; Rizvi QA; Zaidi U; Borhany M; Shamsi T
    Indian J Microbiol; 2019 Jun; 59(2):188-192. PubMed ID: 31031433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.
    Le Clech L; Talarmin JP; Couturier MA; Ianotto JC; Nicol C; Le Calloch R; Dos Santos S; Hutin P; Tandé D; Cogulet V; Berthou C; Guillerm G
    Infect Dis (Lond); 2018 Jul; 50(7):539-549. PubMed ID: 29451055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
    Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
    Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center.
    Karanwal AB; Parikh BJ; Goswami P; Panchal HP; Parekh BB; Patel KB
    Indian J Med Paediatr Oncol; 2013 Apr; 34(2):85-8. PubMed ID: 24049293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
    Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
    Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of severe infections in afebrile neutropenic cancer patients.
    Strojnik K; Mahkovic-Hergouth K; Novakovic BJ; Seruga B
    Radiol Oncol; 2016 Dec; 50(4):442-448. PubMed ID: 27904453
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients.
    Gençer S; Salepçi T; Ozer S
    J Infect; 2003 Jul; 47(1):65-72. PubMed ID: 12850165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy.
    Meir HM; Balawi IA; Meer HM; Nayel H; Al-Mobarak MF
    Saudi Med J; 2001 May; 22(5):423-7. PubMed ID: 11376385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
    Santhosh-Kumar CR; Ajarim DS; Harakati MS; al Momen AK; al Mohareb F; Zeitany RG
    J Infect; 1992 Jul; 25(1):11-9. PubMed ID: 1365011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Rizal AM; Nordiah AJ; Jamal R
    Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
    Avabratha KS; Rau AT; Venkataravanamma P; Rau A
    Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imipenem in the treatment of febrile neutropenic children.
    Erbey F; Bayram I; Yilma S; Tanyeli A
    Asian Pac J Cancer Prev; 2009; 10(5):921-4. PubMed ID: 20104991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The outcome of febrile neutropenic episodes in paediatric oncology at the Wendy Fitzwilliam Paediatric Hospital.
    Timothy M; Bodkyn C
    West Indian Med J; 2011 Mar; 60(2):153-7. PubMed ID: 21942119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience.
    Piukovics K; Terhes G; Lázár A; Tímár F; Borbényi Z; Urbán E
    Eur J Microbiol Immunol (Bp); 2015 Sep; 5(3):199-204. PubMed ID: 26495130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.